Data / Drug companies / Reckitt Benckiser LLC
Reckitt Benckiser LLC: 75 products in the FDA NDC directory, labeler code 72854
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Reckitt Benckiser LLC (labeler code 72854) lists 75 products in the FDA National Drug Code Directory, covering 23 finished drugs by generic name. By type: 70 over the counter drugs, 5 drugs for further processing. Its main marketing category is over the counter monograph drugs. The newest product started marketing on July 1, 2026.
The request: Watch Reckitt Benckiser LLC (FDA labeler code 72854): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 72854
- Products in commercial distribution
- 75
- Packages
- 105
- Finished drugs by generic name
- 23
- Prescription products
- 0
- Over the counter products
- 70
- Flagged as original packager
- 56 of 56 products that carry the flag
- Started marketing in the last 12 months
- 12
- Earliest marketing start
- August 1, 2020
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Over the counter monograph drugs | 67 | 89.3% |
| Drugs for further processing | 5 | 6.7% |
| Generic drugs (ANDA) | 2 | 2.7% |
| New drug applications (NDA) | 1 | 1.3% |
Products by type
| Type | Products | Share |
|---|---|---|
| Over the counter drugs | 70 | 93.3% |
| Drugs for further processing | 5 | 6.7% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Acetaminophen, dextromethorphan hydrobromide | 5 | 20 |
| Acetaminophen, guaifenesin | 4 | 6 |
| Dextromethorphan hydrobromide | 3 | 17 |
| Dextromethorphan hydrobromide, guaifenesin | 3 | 49 |
| Dextromethorphan hbr and doxylamine succinate | 2 | 1 |
| Hexylresorcinol | 2 | 3 |
| Oxymetazoline hci | 2 | 1 |
| Acetaminophen, dextromethorphan hbr, triprolidine hcl | 2 | 8 |
| Oxymetazoline hydrochloride, acetaminophen and guaifenesin | 2 | 1 |
| Acetaminophen and guaifenesin | 2 | 1 |
| Acetaminophen, dextromethorphan hbr | 1 | 20 |
| Naproxen sodium, dextromethorphan hydrobromide, guaifenesin | 1 | 1 |
| Dextromethorphan hbr, guaifenesin | 1 | 67 |
| Acetaminophen, dextromethorphan hbr and doxylamine succinate | 1 | 5 |
| Naproxen sodium, pseudoephedrine hydrochloride | 1 | 3 |
| Acetaminophen and dextromethorphan hydrobromide | 1 | 6 |
| Benzocaine and menthol, unspecified form | 1 | 2 |
| Hexylresorcinol and menthol | 1 | 1 |
| Dextromethorphan hydrobromide, triprolidine hydrochloride | 1 | 1 |
| Dextromethorphan hbr, guaifenesin and triprolidine hcl | 1 | 1 |
| Fluticasone propionate | 1 | 71 |
| Dextromethorphan hydrobromide and hexylresorcinol | 1 | 1 |
| Lidocaine | 1 | 216 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Kit | 21 | 28% |
| Capsule, liquid filled | 15 | 20% |
| Solution | 8 | 10.7% |
| Tablet, coated | 8 | 10.7% |
| Lozenge | 5 | 6.7% |
| Tablet, chewable | 4 | 5.3% |
| Tablet | 4 | 5.3% |
| Spray | 3 | 4% |
| Tablet, extended release | 2 | 2.7% |
| Spray, metered | 2 | 2.7% |
| Liquid | 1 | 1.3% |
| Tablet, film coated | 1 | 1.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Mucinex Nasal Congestion and Allergy Relief | 72854-227 | Spray, metered | Generic drugs (ANDA) | July 1, 2026 |
| Mucinex DS 12HR COLD, FEVER and SINUS | 72854-223 | Tablet, extended release | Generic drugs (ANDA) | July 1, 2026 |
| Mucinex Fast-Max Kickstart Severe Cold and Flu and Mucinex Fast-Max Recharge Nighttime Cold and Flu | 72854-188 | Kit | Over the counter monograph drugs | July 1, 2026 |
| Mucinex Fast-Max DM Max and Mucinex Fast-Max Nighttime DM Max Value Pack | 72854-142 | Kit | Over the counter monograph drugs | July 1, 2026 |
| Mucinex Fastmax Nighttime DM MAX | 72854-141 | Solution | Over the counter monograph drugs | July 1, 2026 |
| Mucinex instasoothe sore throat plus cough sugar free | 72854-268 | Lozenge | Over the counter monograph drugs | June 1, 2026 |
| Mucinex Childrens Multi-Symptom Cold and Flu | 72854-070 | Solution | Over the counter monograph drugs | June 1, 2026 |
| Mucinex Childrens Night Time Multi-Symptom Cold and Flu | 72854-063 | Solution | Over the counter monograph drugs | June 1, 2026 |
| Mucinex Childrens | 72854-062 | Kit | Over the counter monograph drugs | June 1, 2026 |
| Mucinex 12HR Cold and Fever Multi-Symptom | 72854-001 | Tablet, extended release | New drug applications (NDA) | June 1, 2026 |
| Mucinex Childrens Mini Melts Cold and Flu | 72854-090 | Granule | Over the counter monograph drugs | April 5, 2026 |
| Mucinex Fast-Max Recharge Nighttime Cold and Flu | 72854-167 | Solution | Over the counter monograph drugs | March 1, 2026 |
| Mucinex Fast-Max Day Cold and Flu and Mucinex Nightshift Night Severe Cold and Flu Maximum Strength | 72854-169 | Kit | Over the counter monograph drugs | July 1, 2025 |
| Mucinex Fast-Max Severe Congestion and Cough | 72854-157 | Tablet, coated | Over the counter monograph drugs | July 1, 2025 |
| Mucinex Sinus Max Sinus Pressure Severe Congestion | 72854-219 | Spray | Over the counter monograph drugs | June 1, 2025 |
| Mucinex Sinus Max Clear and Cool Severe Congestion | 72854-218 | Spray | Over the counter monograph drugs | June 1, 2025 |
| MUCINEX Rapid Clear Pain, Headache and Mucus Congestion and Nighttime Liquid Gels | 72854-217 | Kit | Over the counter monograph drugs | June 1, 2025 |
| Mucinex Rapid Clear Daytime Pain, Headache, and Cough | 72854-214 | Capsule, liquid filled | Over the counter monograph drugs | June 1, 2025 |
| MUCINEX Rapid Clear Day Night and Clear and Cool Nasal | 72854-213 | Kit | Over the counter monograph drugs | June 1, 2025 |
| Mucinex Sinus Max Clear and Cool | 72854-211 | Capsule, liquid filled | Over the counter monograph drugs | June 1, 2025 |
| MUCINEX DAY TIME PAIN, HEADACHE and MUCUS CONGESTION and MUCINEX NIGHT TIME HEADACHE, COUGH and FEVER Maximum Strength | 72854-210 | Kit | Over the counter monograph drugs | June 1, 2025 |
| Mucinex Fast-Max Cold and Flu Maximum Strength | 72854-171 | Capsule, liquid filled | Over the counter monograph drugs | June 1, 2025 |
| MUCINEX FAST-MAX Liquid Gels Day Night Cold and Flu | 72854-168 | Kit | Over the counter monograph drugs | June 1, 2025 |
| Mucinex Fast-Max Severe Congestion and Cough and Mucinex Nighttime Cold and Flu | 72854-166 | Kit | Over the counter monograph drugs | June 1, 2025 |
| Mucinex Fast-Max DM Max and Mucinex Nighttime Cold and Flu | 72854-165 | Kit | Over the counter monograph drugs | June 1, 2025 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.